Oppenheimer & Co’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.12M Buy
56,907
+19,955
+54% +$409K 0.01% 870
2026
Q2
$721K Buy
36,952
+2,857
+8% +$56.7K 0.01% 1088
2026
Q1
$656K Buy
34,095
+4,025
+13% +$79.3K 0.01% 1072
2025
Q4
$570K Sell
30,070
-3,914
-12% -$72.5K 0.01% 1028
2025
Q3
$633K Buy
33,984
+581
+2% +$10.9K 0.01% 1096
2025
Q2
$616K Buy
33,403
+341
+1% +$6.05K 0.01% 1067
2025
Q1
$578K Buy
+33,062
New +$557K 0.01% 1034
2023
Q4
– Sell
-23,926
Closed -$334K – 1449
2023
Q3
$334K Buy
+23,926
New +$306K 0.01% 1096
2022
Q3
– Sell
-52,731
Closed -$736K – 1454
2022
Q2
$736K Buy
+52,731
New +$705K 0.02% 796
2022
Q1
– Sell
-20,181
Closed -$273K – 1571
2021
Q4
$273K Buy
+20,181
New +$286K ﹤0.01% 1271
2020
Q1
– Sell
-34,765
Closed -$742K – 1314
2019
Q4
$742K Buy
34,765
+611
+2% +$13.7K 0.02% 711
2019
Q3
$783K Buy
34,154
+8,393
+33% +$179K 0.02% 661
2019
Q2
$508K Buy
+25,761
New +$502K 0.01% 800
2019
Q1
– Sell
-18,216
Closed -$301K – 1384
2018
Q4
$301K Sell
18,216
-10,218
-36% -$206K 0.01% 933
2018
Q3
$657K Buy
+28,434
New +$644K 0.02% 753

Other funds holding SBRA

Oppenheimer & Co's SBRA Position: Q3 2026 in Review

Oppenheimer & Co increased its Sabra Healthcare REIT (SBRA) stake by 54% in Q3 2026, buying an estimated $409K and bringing the position to 56,907 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #870.

Oppenheimer & Co first reported a position in SBRA in Q3 2018 and has held it in 15 quarters since. 457 funds tracked by Wall St. Rank hold SBRA as of Q3 2026.

  • Oppenheimer & Co held 56,907 shares of Sabra Healthcare REIT worth $1.12M as of Q3 2026.
  • Oppenheimer & Co bought 19,955 Sabra Healthcare REIT shares in Q3 2026, an estimated $409K.
  • Sabra Healthcare REIT made up 0.01% of Oppenheimer & Co's portfolio in Q3 2026, its #870 holding.
  • Oppenheimer & Co first reported a position in Sabra Healthcare REIT in Q3 2018 and has held it in 15 quarters since.
  • 457 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2026.

Based on Oppenheimer & Co's 13F filing for Q3 2026, filed 26 Oct 2026.